At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 36 enrolled
Drug / intervention
dabigatran etexilate +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor (Part 1 and 2, Open, Non-randomised, 2 Parallel Groups) and Assessment of Ticagrelor Interaction Potential With Dabigatran (Part 3, Open, Randomised, Two-period Cross-over) in Healthy Male Subjects
In Brief
A Phase 1 clinical trial evaluating dabigatran etexilate and Ticagrelor for Healthy. Completed, enrolled 36 participants across 1 site.
Detailed Summary
Evaluation of potential ticagrelor effects on dabigatran exposure and evaluation of two new pharmacodynamic methods
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesGermany
Collaborators--
Timeline
Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2012
First PostedMay 2012
Primary CompletionJun 2012
TodayJul 2026
First PostedMay 10, 2012
Enrollment StartMay 1, 2012
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 14.1 years ago
Interventions
dabigatran etexilatedrug
medium dose dabigatran
Ticagrelordrug
high dose ticagrelor
Ticagrelordrug
high dose ticagrelor
dabigatran etexilatedrug
low dose dabigatran
dabigatran etexilatedrug
medium dose dabigatran